Zhejiang Yongtai Technology Co., Ltd. 2025 Annual Report of Independent Director
As an independent director of Zhejiang Yongtai Technology Co., Ltd. (hereinafter referred to as the "Company"), in 2025, I strictly followed the provisions of the Company Law, the Corporate Governance Guidelines for Listed Companies, the Administrative Measures for Independent Directors of Listed Companies, and other relevant laws, regulations, and the Articles of Association. I diligently exercised the rights granted by the Company, promptly understood the Company's production and operation information, closely followed the Company's development, and actively attended relevant meetings held by the Company in 2025. I expressed independent and objective opinions on matters reviewed by the Board of Directors, faithfully performed my duties, fully leveraged the role of independent director, and protected the overall interests of the Company and the legitimate rights and interests of all shareholders, especially small and medium shareholders. The report on my performance of independent director duties in 2025 is as follows:
I. Basic Information
I, Zhang Weikun, am a Chinese citizen with no permanent overseas residency. I am 57 years old, hold a bachelor's degree, and am a senior accountant. Since May 2011, I have been a teacher and office director at the School of Accounting and Finance, Taizhou Vocational College of Science and Technology. Since August 2022, I have served as an independent director of the Company. I also concurrently serve as an independent director for Zhejiang Taihong Wanli Technology Co., Ltd. and Zhejiang Hongdong Medical Device Co., Ltd.
During the reporting period, my position met the independence requirements stipulated in Article 6 of the Administrative Measures for Independent Directors of Listed Companies, and there were no circumstances affecting my independence.
II. Performance of Duties in 2025
- Attendance at Board and Shareholder Meetings
In 2025, the Company held 8 board meetings, 1 annual general meeting, and 2 extraordinary general meetings. I attended all of them in person.
In 2025, I personally participated in 8 board meetings of the Company and voted on relevant proposals. Of these, 6 were attended in person and 2 were attended via communication. There were no instances of entrusting attendance or absence from meetings. Before the meetings, I carefully reviewed the materials and communicated with relevant personnel. During the meetings, I listened attentively and reviewed each proposal, actively participating in discussions and offering constructive suggestions, thereby faithfully performing my duties as an independent director. I believe that the convening and holding of the Company's board meetings in 2025 complied with legal procedures. Major operational decisions and other significant matters followed the relevant procedures and were legal and effective. Therefore, after thorough communication, except for proposals requiring my recusal, I voted in favor of all proposals at the Company's board meetings in 2025, with no dissenting or abstaining votes.
- Participation in Board Committees and Independent Director Meetings
In 2025, in strict accordance with the relevant requirements of the implementation rules of the Company's various special committees and the "Independent Director Work System," I actively participated in a total of 11 meetings of the Company's various special committees and 1 independent director meeting. I effectively performed my duties as a member of these special committees and an attendee of the independent director meetings, contributing to the scientific decision-making of the Board of Directors.
- Communication with the Internal Audit Department and Accounting Firm
During the reporting period, I communicated multiple times with the Company's internal audit department and accounting firm. I engaged in in-depth discussions and exchanges with the accounting firm regarding periodic reports and financial matters, safeguarding the objectivity and fairness of the audit results.
- Work Done to Protect Investor Rights